Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Polycystic Ovary Syndrome × Tirzepatide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Obesity 9 Endometrial Neoplasms 4 Prostatic Neoplasms 2 Overweight 2 Endometrial Hyperplasia 2 Diabetes Mellitus 2 Breast Neoplasms 2 Weight Loss 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Opioid-Related Disorders 1 Metabolic Syndrome 1 Lymphoma, Follicular 1 Insulin Resistance 1 Inflammation 1 Hyperplasia 1 Dyslipidemias 1 Colorectal Neoplasms 1

Interventions

Metformin 148 Clomiphene 51 Letrozole 40 Inositol 32 Folic Acid 18 Progesterone 17 Exercise 17 Ethinyl Estradiol 13 Estradiol 13 Chorionic Gonadotropin 13 Caloric Restriction 13 drospirenone and ethinyl estradiol combination 12 Contraceptives, Oral 12 cetrorelix 11 High-Intensity Interval Training 10 Cholecalciferol 10 Triptorelin Pamoate 9 Tablets 9 Spironolactone 9 Pioglitazone 9 Menotropins 8 Diet 8 Vitamin D 7 Thioctic Acid 7 Surveys and Questionnaires 7 Liraglutide 7 Gonadotropins 7 Acupuncture Therapy 7 follitropin alfa 6 drospirenone 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07326111 2026-01-08

PERIODS

University of Bonn

Phase 4 Recruiting

Obesity, Polycystic Ovary Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡